Development of a UPLC-MS/MS method for the determination of sulfatinib and its no interaction with myricetin in rats
The findings contributed to a better understanding of the metabolism and drug-drug interaction of sulfatinib, but the presence or absence of interactions needs to be confirmed by further studies.
Authors
- Xuegu Xu
- Dongxin Chen (ORCID: https://orcid.org/0000-0001-8421-0889)
- Xiaohai Chen (ORCID: https://orcid.org/0009-0009-5017-5515)
- Jinyu Hu
- Hailun Xia (ORCID: https://orcid.org/0000-0001-5454-321X)
- Jie Chen (ORCID: https://orcid.org/0000-0002-7503-8236)
- Guangliang Wu
Institutions
- Ningbo University (CN)
- Wenzhou Medical University (CN)
- First Affiliated Hospital of Wenzhou Medical University (CN)
- Affiliated Eye Hospital of Wenzhou Medical College (CN)
- Ningbo Medical Center Lihuili Hospital (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2024-12-04
- DOI
- https://doi.org/10.3389/fphar.2024.1498339
- Citations
- 1
- Primary Topic
- Chronic Myeloid Leukemia Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.45